How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
39
RDI Quote, Financials, Valuation and Earnings
Last price:
$1.26
Seasonality move
:
2.18%
Day range:
$1.18 - $1.26
52-week range:
$1.17 - $1.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.13x
P/B ratio:
5.94x
Volume:
28.1K
Avg. volume:
52K
1-year change:
-28.07%
Market cap:
$27.4M
Revenue:
$210.5M
EPS (TTM):
-$1.88
Analysts' Opinion
-
Consensus RatingReading International has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2.50, Reading International has an estimated upside of 103.25% from its current price of $1.23.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.50 representing 100% downside risk from its current price of $1.23.
Fair Value
-
According to the consensus of 1 analyst, Reading International has 103.25% upside to fair value with a price target of $2.50 per share.
RDI vs. S&P 500
-
Over the past 5 trading days, Reading International has overperformed the S&P 500 by 5.72% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Reading International does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Reading International has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Reading International reported revenues of $60.1M.
Earnings Growth
-
Reading International earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Reading International reported earnings per share of -$0.31.
Enterprise value:
216.4M
EV / Invested capital:
--
Price / LTM sales:
0.13x
EV / EBIT:
--
EV / Revenue:
1.03x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
-56.47x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
74.66x
Gross Profit (TTM):
$17.7M
Return On Assets:
-8.21%
Net Income Margin (TTM):
-21.22%
Return On Equity:
-195.8%
Return On Invested Capital:
-18.36%
Operating Margin:
-0.41%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $203.1M | $222.7M | $210.5M | $45.3M | $58.6M | |
| Gross Profit | $15.4M | $26.6M | $21.9M | $2M | $9.7M | |
| Operating Income | -$26.9M | -$12M | -$14M | -$7M | $1.5M | |
| EBITDA | $1.1M | $8.9M | $2.9M | -$1.9M | $7M | |
| Diluted EPS | -$1.64 | -$1.38 | -$1.57 | -$0.56 | -$0.10 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $56.5M | $100.3M | $47.5M | $38.7M | $57M | |
| Total Assets | $690.2M | $687.7M | $587.1M | $533.1M | $471M | |
| Current Liabilities | $120.6M | $107M | $121.7M | $127.1M | $161.6M | |
| Total Liabilities | $609M | $582.6M | $523.8M | $500.1M | $475.8M | |
| Total Equity | $81.2M | $105.1M | $63.3M | $33M | -$4.8M | |
| Total Debt | $282.6M | $234M | $213.7M | $208.8M | $201.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$26.4M | -$9.7M | -$3.8M | -$3.4M | $8M | |
| Cash From Investing | -$9.5M | -$2.7M | $4M | $3.5M | -$1M | |
| Cash From Financing | -$16.6M | -$6.7M | $337K | -$2.8M | -$1.8M | |
| Free Cash Flow | -$26.4M | -$9.7M | -$3.8M | -$3.4M | $8M | |
RDI
Sector
Market Cap
$27.4M
$77.9M
Price % of 52-Week High
65.08%
61.56%
Dividend Yield
0%
0%
Shareholder Yield
--
3.02%
1-Year Price Total Return
-28.07%
-18.22%
Beta (5-Year)
1.277
0.582
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.22
200-day SMA
Sell
Level
$1.48
Bollinger Bands (100)
Sell
Level
1.29 - 1.55
Chaikin Money Flow
Buy
Level
9.6M
20-day SMA
Sell
Level
$1.27
Relative Strength Index (RSI14)
Sell
Level
43.30
ADX Line
Sell
Level
7.89
Williams %R
Buy
Level
-80.9705
50-day SMA
Sell
Level
$1.37
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
4.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.2233)
Sell
CA Score
(Annual)
Level (-2.5933)
Buy
Beneish M-Score
(Annual)
Level (-3.1094)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (4.7466)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
Stock Forecast FAQ
In the current month, RDI has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RDI average analyst price target in the past 3 months is $2.50.
-
Where Will Reading International Stock Be In 1 Year?
According to analysts, the consensus estimate is that Reading International share price will rise to $2.50 per share over the next 12 months.
-
What Do Analysts Say About Reading International?
Analysts are divided on their view about Reading International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Reading International is a Sell and believe this share price will drop from its current level to $2.50.
-
What Is Reading International's Price Target?
The price target for Reading International over the next 1-year time period is forecast to be $2.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RDI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Reading International is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of RDI?
You can purchase shares of Reading International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Reading International shares.
-
What Is The Reading International Share Price Today?
Reading International was last trading at $1.26 per share. This represents the most recent stock quote for Reading International. Yesterday, Reading International closed at $1.23 per share.
-
How To Buy Reading International Stock Online?
In order to purchase Reading International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
